Pediatrix Medical Group, Inc. (NYSE:MD) Receives Average Recommendation of “Hold” from Brokerages

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have been assigned a consensus rating of “Hold” from the six brokerages that are covering the firm, MarketBeat.com reports. Four analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 1-year price target among analysts that have covered the stock in the last year is $16.67.

MD has been the topic of a number of research reports. Macquarie raised their price objective on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an “outperform” rating in a report on Thursday, May 8th. UBS Group decreased their target price on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a “neutral” rating on the stock in a research note on Monday, May 12th. Finally, Truist Financial decreased their target price on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating on the stock in a research note on Friday, April 11th.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. increased its position in Pediatrix Medical Group by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 10,812,611 shares of the company’s stock valued at $141,861,000 after acquiring an additional 113,976 shares during the last quarter. Boston Partners increased its position in Pediatrix Medical Group by 1.3% during the first quarter. Boston Partners now owns 1,981,889 shares of the company’s stock valued at $27,990,000 after acquiring an additional 25,536 shares during the last quarter. Geode Capital Management LLC increased its position in Pediatrix Medical Group by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 1,947,796 shares of the company’s stock valued at $25,562,000 after acquiring an additional 11,045 shares during the last quarter. American Century Companies Inc. increased its position in Pediatrix Medical Group by 628.2% during the fourth quarter. American Century Companies Inc. now owns 1,739,323 shares of the company’s stock valued at $22,820,000 after acquiring an additional 1,500,485 shares during the last quarter. Finally, Northern Trust Corp increased its position in Pediatrix Medical Group by 18.0% during the fourth quarter. Northern Trust Corp now owns 966,347 shares of the company’s stock valued at $12,678,000 after acquiring an additional 147,522 shares during the last quarter. Institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Stock Performance

Shares of NYSE MD opened at $12.57 on Friday. The firm’s 50-day moving average price is $13.83 and its 200-day moving average price is $13.86. The company has a quick ratio of 1.81, a current ratio of 1.81 and a debt-to-equity ratio of 0.75. The company has a market cap of $1.08 billion, a PE ratio of -12.45, a PEG ratio of 0.87 and a beta of 1.25. Pediatrix Medical Group has a 52-week low of $7.40 and a 52-week high of $17.67.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.25 by $0.08. The firm had revenue of $458.36 million for the quarter, compared to the consensus estimate of $451.44 million. Pediatrix Medical Group had a negative net margin of 4.17% and a positive return on equity of 17.43%. The business’s quarterly revenue was down 7.4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.20 EPS. As a group, analysts anticipate that Pediatrix Medical Group will post 1.38 EPS for the current year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.